Literature DB >> 9781809

Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-alpha in chronic hepatitis C.

C Fabris1, G Soardo, E Falleti, P Toniutto, D Vitulli, E Federico, M Del Forno, M Mattiuzzo, F Gonano, M Pirisi.   

Abstract

To investigate the relationship among circulating cytokines, inflammation in the liver, and kind of response to interferon-alpha (IFN-alpha) in hepatitis C, we studied 63 consecutive patients (38 male, 25 female), treated with IFN for up to 1 year. Serum tumor necrosis factor-alpha (TNF-alpha) was measured at baseline and after 3 months of treatment. Transient (TR) or sustained response (SR) was observed in 29 and 16 patients, respectively. Baseline levels of TNF < or = 22 ng/L were observed in 69% of patients with SR, 55% of patients with TR, and 22% of nonresponders (p < 0.01). There was a significant correlation between baseline TNF levels and histologic grading score of hepatitis (p < 0.01). After 3 months of treatment, TNF levels >22 ng/L were observed in 63% of patients with SR, 69% of patients with TR, and 83% of nonresponders (p NS). Independent of the treatment outcome, TNF levels were lower at baseline and increased significantly with treatment in patients with lower histologic grading (p < 0.005). In conclusion, in patients with chronic hepatitis C, circulating TNF levels correlate with the degree of inflammation in the liver. Response to IFN is accompanied by an inflammatory response involving the release of TNF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781809     DOI: 10.1089/jir.1998.18.705

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

1.  Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.

Authors:  Marc Weeber; Rein Vos; Henny Klein; Lolkje T W De Jong-Van Den Berg; Alan R Aronson; Grietje Molema
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

2.  Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.

Authors:  Zaigham Abbas; Tariq Moatter; Akber Hussainy; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

3.  Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.

Authors:  C Fabris; M Del Forno; E Falleti; P Toniutto; M Pirisi
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

4.  Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism.

Authors:  Ali Mandegary; Arastoo Saeedi; Aziz Eftekhari; Vahideh Montazeri; Elham Sharif
Journal:  Daru       Date:  2013-04-08       Impact factor: 3.117

5.  Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.

Authors:  Sara Corchado; Mercedes Márquez; Montserrat Montes de Oca; Paula Romero-Cores; Clotilde Fernández-Gutiérrez; José-Antonio Girón-González
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

6.  Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.

Authors:  Sara Corchado; Luis F López-Cortés; Antonio Rivero-Juárez; Almudena Torres-Cornejo; Antonio Rivero; Mercedes Márquez-Coello; José-Antonio Girón-González
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.